A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21 (Q81661553)
Jump to navigation
Jump to search
scientific article published on 01 May 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21 |
scientific article published on 01 May 2005 |
Statements
A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21 (English)
Howard I Scher
Govind Ragupathi
Celina Fernandez
Matthew P Jefferson
Meghan Diani
Andrew S Wilton
Shemeeakah Powell
Maria Spassova
Henrick Clausen
Samuel Danishefsky
Philip Livingston
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference